Palatin takes faster appendicitis diagnostic to the US
This article was originally published in Clinica
Executive Summary
The US FDA has given Palatin Technologies the go-ahead to market an in vivo imaging agent that can help doctors diagnose appendicitis several hours faster than the current ex vivo methods.